An Evaluation of Hepatitis E Virus Molecular Typing Methods
Author:
Baylis Sally A1, Adlhoch Cornelia2ORCID, Childs Liam3, Stühler Anett, Karlsson Marie, Molier Michel, Suin Vanessa, Lamoral Sophie, Nasheri NedaORCID, Harlow Jennifer, Rešetnjak Irina, Abravanel Florence, Lhomme Sebastien, Izopet Jacques, Pavio Nicole, Pellerin Marie, Eiden Martin, Boettcher Birke, Kaiser Marco, Schilling-Loeffler Katja, Johne Reimar, Schwarz Tatjana, Corman Victor M, Wenzel Jürgen JORCID, Klein Jasmin, Bennett Charlene, DeGascun Cillian, Dean Jonathan, Ciccaglione Anna Rita, Villano Umbertina, Bruni Roberto, Di Bartolo Ilaria, De Sabato Luca, La Rosa Giuseppina, Ferraro Giusy Bonanno, Mancini Pamela, Suffredini ElisabettaORCID, Garbuglia Anna Rosa, Boxman Ingeborg, Dirks René, Zwartkruis-Nahuis Ans, Hogema Boris, de Sousa Rita, Velebit Branko, Avellón Ana, Sánchez Gloria, Cuevas-Ferrando Enric, Norder Heléne, Bachofen Claudia, Vonlanthen Isabelle, Kubacki Jakub, Lacher David, Mammel Mark, Kulka Michael,
Affiliation:
1. Viral Safety Section, Paul-Ehrlich-Institut, Langen, Germany 2. Disease Programmes Unit, European Centre for Disease Prevention and Control, Solna, Sweden 3. Host-Pathogen Interactions, Paul-Ehrlich-Institut, Langen, Germany
Abstract
Abstract
Background
Hepatitis E virus (HEV) is a major cause of acute viral hepatitis. Better understanding of HEV subtypes involved in hepatitis E infections is essential. Investigation of sources and routes of transmission and the identification of potential clusters/outbreaks rely upon molecular typing of viral strains. A study was carried out to evaluate the ability of laboratories to undertake molecular typing with genotype and subtype determination.
Methods
A blinded panel of 11 different Orthohepevirus A strains was distributed to 28 laboratories performing HEV sequence analysis. Laboratories used their routine HEV sequencing and genotyping methods.
Results
Results were returned by 25 laboratories. Overall, 93% samples were assigned to the correct genotype and 81% were assigned to the correct subtype. Fragments amplified for typing ranged in size and the sequencing assays targeted both the structural and non-structural protein-coding regions. There was good agreement between the reported sequences where methods targeted overlapping fragments. In some cases, incorrect genotypes/subtypes were reported, including those not contained in the panel, and in one case, a genotype was reported for a blinded control sample containing Zika virus; collectively these data indicate contamination problems.
Conclusions
In general, identification of genotypes was good; however, in a small number of cases, there was a failure to generate sequences from some of the samples. There was generally broad agreement between the use of online typing tools such as the one provided by HEVnet and curated lists of published HEV reference sequences; however, going forward harmonization between these resources is essential.
Funder
European Centre for Disease Prevention and Control Health Canada internal funds
Publisher
Oxford University Press (OUP)
Subject
Biochemistry (medical),Clinical Biochemistry
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|